About Garphi Biosciences Private Limited
Data last updated:
Garphi Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 15 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2008PTC058678. Its GSTIN is 36AADCG1945J1ZJ (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Venkat Kamalakar Bundla (Managing Director) and Padmaja Bundla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No : 401 Millennium Square Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.15 Cr, a decline of 59% compared to the previous year. For the same year it recorded a net profit of ₹80,200 (net margin 0.7%) and EBITDA of ₹11.32 Lakh (EBITDA margin 9.9%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years and 26% over five years.
The company is associated with 1 brand: Garphi Biosciences.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website garphi.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No : 401 Millennium Square Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Garphi Biosciences Private Limited
The main business activity of Garphi Biosciences is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Garphi Biosciences Private Limited FY 2025 filings available
Garphi Biosciences Private Limited reported revenue of ₹1.15 Cr (down 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Garphi Biosciences Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 59% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Garphi Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹1.15 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹80,200 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Garphi Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Garphi Biosciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Garphi Biosciences Private Limited
Garphi Biosciences Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Biosciences, Consulting Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Garphi Biosciences Private Limited this company | ₹1.15 Cr (FY 2025) | •••• | •••• | -59.0% | •••• | Hyderabad, Telangana, India |
| Royal Visa Advisors Private Limited | ₹58.97 Lakh (FY 2024) | •••• | •••• | -32.0% | •••• | Amritsar, Punjab, India |
| Otrio Ventures Private Limited | ₹58.94 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Auranagabad, Maharashtra, India |
| Selah Business Solutions Private Limited | ₹58.93 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Bangalore, Karnataka, India |
| Meghraj Capital Advisors Private Limited | ₹58.9 Lakh (FY 2025) | •••• | •••• | -53.0% | •••• | Mumbai, Maharashtra, India |
| Nafa General Partners Private Limited | ₹58.89 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Panarc Consulting Group Private Limited | ₹58.87 Lakh (FY 2025) | •••• | •••• | 104.0% | •••• | New Delhi, Delhi, India |
| Makk Safety and Risk Services Private Limited | ₹58.87 Lakh (FY 2020) | •••• | •••• | -59.0% | •••• | Pathankot, Punjab, India |
| Agilewow Consulting Services Private Limited | ₹58.87 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Gurugram, Haryana, India |
| Bstone Tech Innovations Private Limited | ₹58.81 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Gurgaon, Haryana, India |
| Attain Vision Business Services Private Limited | ₹58.79 Lakh (FY 2024) | •••• | •••• | -51.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Garphi Biosciences by revenue in the Outsourcing industry (Biosciences, Consulting Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Garphi Biosciences Private Limited
Garphi Biosciences Private Limited is audited by VASANTHA RAO & ASS0CIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VASANTHA RAO & ASS0CIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Garphi Biosciences Private Limited
Garphi Biosciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikita Bundla | Additional Director | 02 Apr 2020 | 6 Years 6 Months | Current |
| Padmaja Bundla Also directs: Biodoz Therapeutics Private Limited | Director | 15 Apr 2008 | 18 Years 6 Months | Current |
| Venkat Kamalakar Bundla | Managing Director | 15 Apr 2008 | 18 Years 6 Months | Current |
Ownership and Shareholding of Garphi Biosciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Garphi Biosciences Private Limited
Garphi Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Garphi Biosciences Private Limited
Garphi Biosciences operates one associated brand: Garphi Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers consulting services for contract manufacturing and product strategy development. | garphi.com |
Employees and EPFO Compliance at Garphi Biosciences Private Limited
Employment history and EPFO contributions of people linked to Garphi Biosciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Garphi Biosciences Private Limited
Garphi Biosciences has one previous CIN (Corporate Identification Number): U73100AP2008PTC058678. The current CIN is U73100TG2008PTC058678, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2008PTC058678 | Current |
| U73100AP2008PTC058678 | Previous |
Recent Activity on Garphi Biosciences Private Limited
Garphi Biosciences Private Limited has 3 board changes on record since 2008: 3 appointments. The latest: Nikita Bundla was appointed as Additional Director on 02 Apr 2020.
Credit Ratings, Litigation & Regulatory Alerts for Garphi Biosciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Garphi Biosciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Garphi Biosciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Garphi Biosciences Private Limited
Garphi Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCG1945J1ZJ | Telangana | Active | 20 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Garphi Biosciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Garphi Biosciences Private Limited
Garphi Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 15 April 2008 (18+ years old) and is registered under CIN U73100TG2008PTC058678.
Garphi Biosciences reported revenue of ₹1.15 Cr for FY 2025 (down 59% YoY).
Garphi Biosciences has 3 current directors:
- Venkat Kamalakar Bundla - Managing Director
- Nikita Bundla - Additional Director
- Padmaja Bundla - Director
Garphi Biosciences reported a net profit of ₹80,200 (net margin 0.7%) and EBITDA of ₹11.32 Lakh (EBITDA margin 9.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Garphi Biosciences is -48% over three years and -26% over five years. In the latest year (FY 2025) revenue fell 59%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Garphi Biosciences is 36AADCG1945J1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Garphi Biosciences is U73100TG2008PTC058678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Garphi Biosciences was incorporated on 15 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Garphi Biosciences by revenue are Royal Visa Advisors Private Limited, Otrio Ventures Private Limited, Selah Business Solutions Private Limited, Meghraj Capital Advisors Private Limited, Nafa General Partners Private Limited and 5 more, all in the Outsourcing industry (Biosciences, Consulting Services).
Nikita Bundla was appointed as Additional Director on 02 Apr 2020. Padmaja Bundla was appointed as Director on 15 Apr 2008. Venkat Kamalakar Bundla was appointed as Managing Director on 15 Apr 2008.
Garphi Biosciences can be reached through the website garphi.com. Its registered office is in Hyderabad, Telangana, India.